Personalized medicine and inhibition of EGFR signaling in lung cancer

Adi F. Gazdar

Research output: Contribution to journalArticle

135 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1018-1020
Number of pages3
JournalNew England Journal of Medicine
Volume361
Issue number10
DOIs
StatePublished - Sep 3 2009

Fingerprint

Precision Medicine
Lung Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Personalized medicine and inhibition of EGFR signaling in lung cancer. / Gazdar, Adi F.

In: New England Journal of Medicine, Vol. 361, No. 10, 03.09.2009, p. 1018-1020.

Research output: Contribution to journalArticle

@article{2ed32cf0eabd4b5583e2d1f7c063c779,
title = "Personalized medicine and inhibition of EGFR signaling in lung cancer",
author = "Gazdar, {Adi F.}",
year = "2009",
month = "9",
day = "3",
doi = "10.1056/NEJMe0905763",
language = "English (US)",
volume = "361",
pages = "1018--1020",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",

}

TY - JOUR

T1 - Personalized medicine and inhibition of EGFR signaling in lung cancer

AU - Gazdar, Adi F.

PY - 2009/9/3

Y1 - 2009/9/3

UR - http://www.scopus.com/inward/record.url?scp=69949126786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949126786&partnerID=8YFLogxK

U2 - 10.1056/NEJMe0905763

DO - 10.1056/NEJMe0905763

M3 - Article

C2 - 19692681

AN - SCOPUS:69949126786

VL - 361

SP - 1018

EP - 1020

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 10

ER -